Molecular Diagnostics Market Analysis of Key Players, Growth Analysis, Demand by Regions, Types and Research Forecasts to 2023

Global Molecular Diagnostics Market was valued at $5,962 million in 2016, and is expected to garner $10,557 million by 2023, registering a CAGR of 9.1% during the forecast period 2017-2023. Molecular diagnostic tests are used to detect specific sequences in DNA or RNA, including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, and others to further diagnose the disease. These are cumulative techniques for analyzing biological markers at the molecular level, such as genome and proteome. These techniques are used for diagnosis of the various infectious diseases, cancer, and others and is also used to check the genetic predisposition to a disease.

The factors such increase in the prevalence of the infectious diseases and various types of cancer, increase in awareness and acceptance of personalized medicines, growth in the biomarker identification, and advancement in molecular diagnostics drive the market growth. Stringent regulatory requirements for the approval of new molecular diagnostics techniques hampers the growth of the market. However, increase in adoption of the molecular diagnostics in the emerging economies provide growth opportunities for the market.

Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-sample/2170

Segment Review

The global molecular diagnostics market is segmented based on type, technology, application, end user, and geography. Based on type, it is classified into instruments, reagents, and software & services. The reagents segment contributed the highest share in 2016, owing to the rise in demand for solutions, quality control reagents, and different reagents for different tests. Based on technology, it is categorized into polymerase chain reaction (PCR), hybridization, DNA sequencing, microarray, isothermal nucleic acid amplification technology (INAAT), and others (electrophoresis, mass spectroscopy, and flow cytometry). PCR contributed to the highest share in 2016, owing to the increase in usage in proteomics and genomics, which is highly cost-effective. Based on application, it is divided into infectious diseases, oncology, genetic testing, blood screening, and others (Microbiology, neurological diseases, and cardiovascular diseases).

Infectious diseases accounted for the highest market share in 2016, owing to the increase in the number of patients suffering from infectious diseases.
Based on end user, it is categorized into hospitals, reference laboratories, and others (blood banks, home health agencies, and nursing homes). Hospitals accounted for the highest market share in the global market in 2016, owing to the increase in the number of patients treated in hospitals.

Top Investment Pockets

The global molecular diagnostics market is segmented by application into infectious diseases, oncology, genetic testing, blood screening, and others (microbiology, neurological diseases, and cardiovascular diseases). Infectious diseases projected the highest revenue in 2016, with a CAGR of 9.3% for the forecast period of 2017-2023, owing to increase in the number of patients suffering from different viral and bacterial infections, such as Human Immunodeficiency Virus (HIV), Hepatitis C virus(HCV), Human Papillomavirus(HPV), Chlamydia trachomatis/ Neisseria gonorrhoeae (CT/NG), and others. Along with the improving healthcare facilities treating these diseases in the emerging nations.

Geographic Analysis

Geographically, the global molecular diagnostics market is segmented into North America, Europe, Asia-Pacific, and LAMEA. The North American molecular diagnostics market accounted for the highest market share in 2016, owing to the factors such as, large aging population, rise in number of cases of infectious and chronic diseases, and increase in awareness of personalized medicines. The European molecular diagnostics market is the second highest revenue generator, owing to well-penetrated healthcare system and favorable regulatory policies. The Asia-Pacific is expected to show the highest growth in the global molecular diagnostics market from 2017 to 2023, with an estimated CAGR of 10.1% owing to the improvement in healthcare facilities to treat the increasing patient population for infectious diseases and various types of cancer.

Do Purchase Enquiry at : https://www.alliedmarketresearch.com/purchase-enquiry/2170

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.